Literature DB >> 7173172

Antimicrobial susceptibility of Gemella haemolysans isolated from patients with subacute endocarditis.

A Buu-Hoï, A Sapoetra, C Branger, J F Acar.   

Abstract

Gemella haemolysans, a member of the family Streptococcacae, was isolated from patients with subacute endocarditis. The minimal inhibitory concentrations of 21 antimicrobial agents for five strains of the organism were determined. All strains were highly sensitive to penicillin G and ampicillin. Cefotaxime was the most active cephalosporin tested. All strains were sensitive to vancomycin, chloramphenicol and rifampin. Four strains were sensitive to tetracycline and erythromycin. All strains demonstrated a low level of resistance to aminoglycosides and were highly resistant to sulfonamides and trimethoprim. Killing curves and checker-board titration demonstrated synergism between penicillin G and streptomycin or gentamicin, and also between vancomycin and streptomycin or gentamicin. The results suggest that penicillin G combined with an aminoglycoside can be recommended for the treatment of subacute endocarditis caused by Gemella haemolysans.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7173172     DOI: 10.1007/bf02014200

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  4 in total

1.  [Simplified technic for studying bactericidal action of combined antibiotics].

Authors:  Y CHABBERT
Journal:  Ann Inst Pasteur (Paris)       Date:  1953-07

2.  An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics.

Authors:  E STEERS; E L FOLTZ; B S GRAVES
Journal:  Antibiot Chemother (Northfield)       Date:  1959-05

3.  Fine structure and taxonomic position of Neisseria haemolysans (Thjotta and Boe 1938) or Gemella haemolysans (Berger 1960).

Authors:  A Reyn; A Birch-Andersen; U Berger
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

4.  Conjugative transfer of multiple antibiotic resistance markers in Streptococcus pneumoniae.

Authors:  A Buu-Hoï; T Horodniceanu
Journal:  J Bacteriol       Date:  1980-07       Impact factor: 3.490

  4 in total
  26 in total

1.  Antimicrobial susceptibility and clinical sources of Dolosigranulum pigrum cultures.

Authors:  L Laclaire; R Facklam
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

2.  Prosthetic valve endocarditis by Gemella haemolysans.

Authors:  P Morea; M Toni; M Bressan; P Stritoni
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

3.  Gemella bacteraemia characterised by 16S ribosomal RNA gene sequencing.

Authors:  P C Y Woo; S K P Lau; A M Y Fung; S K Chiu; R W H Yung; K Y Yuen
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

4.  Ocular infection secondary to gemella.

Authors:  Pedram Hamrah; David Ritterband; John Seedor; Richard A Eiferman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

5.  Meningitis due to Gemella haemolysans.

Authors:  T May; C Amiel; C Lion; M Weber; A Gerard; P Canton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

6.  Meningitis due to Gemella haemolysans after radiofrequency trigeminal rhizotomy.

Authors:  R G Mitchell; P J Teddy
Journal:  J Clin Pathol       Date:  1985-05       Impact factor: 3.411

7.  Prevalence of Gemella haemolysans on the pharyngeal mucosa of man.

Authors:  U Berger
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

8.  Endocarditis caused by Gemella haemolysans.

Authors:  A Kaufhold; D Franzen; R Lütticken
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

9.  Acute postoperative endophthalmitis by Gemella haemolysans.

Authors:  Suma Nalamada; Subhadra Jalali; Ashok Kumar Reddy
Journal:  Indian J Ophthalmol       Date:  2010 May-Jun       Impact factor: 1.848

10.  Brain abscess due to Gemella haemolysans.

Authors:  Mi Ra Lee; Sang-Oh Lee; Sue-Yun Kim; Sun Mee Yang; Yiel-Hae Seo; Yong Kyun Cho
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.